Cowan Elvia 4
4 · Vaxcyte, Inc. · Filed Dec 18, 2024
Insider Transaction Report
Form 4
Vaxcyte, Inc.PCVX
Cowan Elvia
SVP, FINANCE
Transactions
- Exercise/Conversion
Common Stock
2024-12-16$25.92/sh+7,716$199,999→ 19,294 total - Exercise/Conversion
Stock Option (right to buy)
2024-12-16−7,716→ 106,284 totalExercise: $25.92Exp: 2032-08-08→ Common Stock (7,716 underlying)
Footnotes (1)
- [F1]1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date.